Spectinomycin Hydrochloride Soluble Powder

Pharmacological actions:
Spectinomycin belongs to the aminoglycoside class of antibiotics and has a moderate inhibitory effect on various Gram-negative bacteria such as E. coli, Salmonella, Shigella, and Proteus. It is sensitive to Streptococcus, pneumococcus, Staphylococcus aureus, and some Mycoplasma (such as Mycoplasma gallisepticum, Mycoplasma meleagridis, and Mycoplasma synoviae). It is generally not sensitive to Streptococcus viridans and Staphylococcus aureus. Pseudomonas aeruginosa and spirochetes are usually resistant to it.

Actions and Uses: Aminoglycoside antibiotic. Used for infections caused by Gram-negative bacteria and Mycoplasma.

Introduction to Spectinomycin Hydrochloride Soluble Powder
Spectinomycin hydrochloride soluble powder is a broad-spectrum antibiotic that is commonly used in veterinary medicine. It is effective against a variety of bacteria, including Gram-positive and Gram-negative bacteria. The medication is available in a powder form that can be easily mixed with water and administered orally to animals.
Spectinomycin hydrochloride soluble powder is primarily used to treat respiratory and urogenital tract infections in livestock, but it can also be used to treat other bacterial infections. The medication is fast-acting and provides long-lasting protection against bacterial infections.
Indications
Spectinomycin hydrochloride soluble powder is indicated for the treatment and prevention of bacterial infections in livestock, including:
Respiratory infections caused by Mycoplasma, Pasteurella, and Haemophilus bacteria.
Urogenital tract infections caused by E. coli and other bacteria.
Other bacterial infections, such as metritis and arthritis.
Dosage and Administration
The recommended dosage of spectinomycin hydrochloride soluble powder is 20-40 mg/kg body weight per day for a period of 3-5 days. The medication should be dissolved in water and administered orally to the animals. The medicated water should be the only source of drinking water during the treatment period.